(3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

C23H33FN4O — CID 118442811

IUPAC(3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILESC=C(Cn1ncnn1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@](O)(CF)CC[C@@H]4[C@H]3CC[C@]12C
InChIInChI=1S/C23H33FN4O/c1-15(12-28-26-14-25-27-28)20-5-6-21-19-4-3-16-11-23(29,13-24)10-8-17(16)18(19)7-9-22(20,21)2/h3,14,17-21,29H,1,4-13H2,2H3/t17-,18+,19+,20+,21-,22+,23-/m0/s1
InChIKeyLSDUJSJQQNAQAZ-ZYOCQLIYSA-N
MW400.54 g/mol
LogP4.12
Rot. Bonds4

About (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (PubChem CID 118442811) has the molecular formula C23H33FN4O and a molecular weight of 400.54 g/mol. Its IUPAC name is (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.

Molecular Properties

Compound Name(3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
PubChem CID118442811
Molecular FormulaC23H33FN4O
Molecular Weight400.54 g/mol
Exact Mass400.26
IUPAC Name(3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
SMILESC=C(Cn1ncnn1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@](O)(CF)CC[C@@H]4[C@H]3CC[C@]12C
InChIInChI=1S/C23H33FN4O/c1-15(12-28-26-14-25-27-28)20-5-6-21-19-4-3-16-11-23(29,13-24)10-8-17(16)18(19)7-9-22(20,21)2/h3,14,17-21,29H,1,4-13H2,2H3/t17-,18+,19+,20+,21-,22+,23-/m0/s1
InChIKeyLSDUJSJQQNAQAZ-ZYOCQLIYSA-N
XLogP4.12
TPSA63.83 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500400.54
LogP ≤ 54.12
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The IUPAC name of (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (CID 118442811) is (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.
What is the SMILES notation for (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The canonical SMILES for (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol is C=C(Cn1ncnn1)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@](O)(CF)CC[C@@H]4[C@H]3CC[C@]12C.
What is the InChIKey of (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
The InChIKey is LSDUJSJQQNAQAZ-ZYOCQLIYSA-N. The full InChI is InChI=1S/C23H33FN4O/c1-15(12-28-26-14-25-27-28)20-5-6-21-19-4-3-16-11-23(29,13-24)10-8-17(16)18(19)7-9-22(20,21)2/h3,14,17-21,29H,1,4-13H2,2H3/t17-,18+,19+,20+,21-,22+,23-/m0/s1.
What are the key properties of (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol?
(3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol has a molecular weight of 400.54 g/mol, XLogP of 4.12, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,8R,9S,10R,13S,14S,17S)-3-(fluoromethyl)-13-methyl-17-[3-(tetrazol-2-yl)prop-1-en-2-yl]-2,4,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol is sourced from PubChem (CID 118442811), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).